Literature DB >> 21732364

Duplicated chromosomal fragments stabilize shortened telomeres in normal human IMR-90 cells before transition to senescence.

Sebastian Zahnreich1, Damir Krunic, Larissa Melnikova, Agnes Szejka, Barbara Drossel, Laure Sabatier, Marco Durante, Sylvia Ritter, Claudia Fournier.   

Abstract

To assess why during in vitro aging of fibroblasts the maintenance of chromosomal stability is effective or occasionally fails, a detailed cytogenetic analysis was performed in normal human IMR-90 fetal lung fibroblasts. The onset of senescence was inferred from proliferation activity, expression pattern of cell cycle regulating proteins, activity of β-galactosidase, and morphological features. Over the period of proliferation, a moderate increase of non-transmissible structural chromosomal aberrations was observed. In addition, using fluorescence in situ hybridization (mFISH and mBAND) techniques, we detected clonally expanding translocations in up to 70% of the analyzed metaphases, all involving one homolog of chromosome 9 as an acceptor. Notably, chromosomes are randomly involved as donor-chromosomes of the translocated terminal acentric fragments. These fragments result from duplication because the donor chromosomes are apparently unchanged. Interstitial telomeric signals were detectable at fusion sites, most likely belonging to chromosome 9. Quantitative fluorescence in situ hybridization (QFISH) detecting telomere sequences, followed by mFISH technique revealed that already in young cells the respective telomeres of one chromosome 9 were particularly short. For the first time, we have observed dysfunctional telomeres of one specific chromosome in normal human cells that have been stabilized by duplicated terminal sequences.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 21732364     DOI: 10.1002/jcp.22921

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  5 in total

1.  JNK suppression of chemotherapeutic agents-induced ROS confers chemoresistance on pancreatic cancer stem cells.

Authors:  Shuhei Suzuki; Masashi Okada; Keita Shibuya; Manabu Seino; Atsushi Sato; Hiroyuki Takeda; Shizuka Seino; Takashi Yoshioka; Chifumi Kitanaka
Journal:  Oncotarget       Date:  2015-01-01

2.  Secretome of adipose-derived mesenchymal stem cells promotes skeletal muscle regeneration through synergistic action of extracellular vesicle cargo and soluble proteins.

Authors:  Robert Mitchell; Ben Mellows; Jonathan Sheard; Manuela Antonioli; Oliver Kretz; David Chambers; Marie-Theres Zeuner; James E Tomkins; Bernd Denecke; Luca Musante; Barbara Joch; Florence Debacq-Chainiaux; Harry Holthofer; Steve Ray; Tobias B Huber; Joern Dengjel; Paolo De Coppi; Darius Widera; Ketan Patel
Journal:  Stem Cell Res Ther       Date:  2019-04-05       Impact factor: 6.832

3.  In vitro and in vivo anti-tumor effects of brexpiprazole, a newly-developed serotonin-dopamine activity modulator with an improved safety profile.

Authors:  Shuhei Suzuki; Masahiro Yamamoto; Keita Togashi; Tomomi Sanomachi; Asuka Sugai; Shizuka Seino; Takashi Yoshioka; Chifumi Kitanaka; Masashi Okada
Journal:  Oncotarget       Date:  2019-05-28

4.  The fate of a normal human cell traversed by a single charged particle.

Authors:  C Fournier; S Zahnreich; D Kraft; T Friedrich; K O Voss; M Durante; S Ritter
Journal:  Sci Rep       Date:  2012-09-10       Impact factor: 4.379

5.  Increased effectiveness of carbon ions in the production of reactive oxygen species in normal human fibroblasts.

Authors:  Till Dettmering; Sebastian Zahnreich; Miriam Colindres-Rojas; Marco Durante; Gisela Taucher-Scholz; Claudia Fournier
Journal:  J Radiat Res       Date:  2014-10-10       Impact factor: 2.724

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.